- 询价
- 2025年10月08日
15 年金牌会员
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 运输方式：
冻存运输
- ATCC Number：
CRL-2615™
- 库存：
大量
- 年限：
43 years
- 物种来源：
人
- 是否是肿瘤细胞：
0
- 细胞类型：
其他细胞类型
- 器官来源：
其他
- 生长状态：
贴壁生长
- 细胞形态：
上皮样
| Designations: | End1/E6E7 | ||
| Depositors: | D Anderson, RN Fichorova, JG Rheinwald | ||
| Biosafety Level: | 2 [Cells contain human Papilloma viral sequences ] | ||
| Shipped: | frozen | ||
| Medium & Serum: | See Propagation | ||
| Growth Properties: | adherent | ||
| Organism: | Homo sapiens deposited as human | ||
| Morphology: | epithelial |
||
| Source: | Organ: endocervix; cervix Cell Type: epithelialHPV-16 E6/E7 transformed |
||
| Cellular Products: | cytokeratins 8 (CK8), 18 (CK18) and 19 (CK19) [52983 ] macrophage colony-stimulating factor (M-CSF); transforming growth factor beta1; IL-6; IL-7; IL-8; prostaglandin E2; secretory leukoproteinase inhibitor; polymeric immunoglobulin receptor; RANTES [52984 ] |
||
| Permits/Forms: | In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. | ||
| Restrictions: | The line is available with the following restrictions: 1. This cell line was deposited at the ATCC by Dr. Deborah Anderson of The Brigham and Women's Hospital, Inc. and is provided for academic research purposes only. Neither the cell line nor products derived from it may be sold or used for commercial purposes, including screening of compounds. Nor can the cells be distributed to third parties for purposes of sale, or producing for sale, cells or their products. The cells are provided as a service to the research community. They are provided without warranty of merchantability or fitness for a particular purpose or any other warranty, express or implied. 2. All products derived from the cells or genetically altered forms of the cells cannot be commercialized without express written permission from the The Brigham and Women's Hospital, Inc. 3. Any proposed commercial manufacture, use, or sale of the these cells, or their products must first be approved and the terms for such commercial manufacture, use, or sale must first be negotiated with TheBrigham and Women's Hospital, Inc., Office of Corporate Sponsored Research and Licensing, 75 Francis Street, Boston, MA 02115 (617) 525-6010. | ||
| Isolation: | Isolation date: 1996 | ||
| Age: | 43 years | ||
| Gender: | female | ||
| Comments: | The ectocervical Ect1/E6E7 (ATCC CRL-2614 ) and endocervical End1/E6E7 (ATCC CRL-2615 ) cell lines were established in 1996 from normal epithelial tissue taken from a premenopausal woman undergoing hysterectomy for endometriosis. [52983 ] The VK2/E6E7 (ATCC CRL-2616 cell line was established in 1996 from the normal vaginal mucosal tissue taken from a premenopausal woman undergoing anterior-posterior vaginal repair surgery. [52983 ] Cells at passage 3 were immortalized by transduction with the retroviral vector LXSN-16E6E7 in the presence of polybrene. Clones were selected in medium containing G418. [52983 ] The endocervical cell line expresses characteristics of simple columnar epithelium, whereas the ectocervical and vaginal cell lines express characteristics of stratified squamous nonkeratinizing epithelia. [52984 ] Without stimulation, all three cell lines produce macrophage colony-stimulating factor (M-CSF), transforming growth factor beta1, interleukin 8 (IL-8), prostaglandin E2, the secretory leukoproteinase inhibitor, and the polymeric immunoglobulin receptor. [52984 ] The endocervical cell line (End1/E6E7), but not the others, also produce the lymphopoietic cytokines IL-6, IL-7, and consistently detectable levels of the chemokine known as "regulated-upon-activation, normal T cell expressed and secreted" (RANTES). [52984 ] Stimulation with interferon gamma and tumor necrosis factor alpha (TNF alpha) induces or significantly up-regulates expression of several of the cytokines and chemokines as well as major histocompatibility complex (MHC) class II antigens in the lines. [52984 ] Piliated, but not nonpiliated, Neisseria gonorrhoea strain F62 variants actively invade these epithelial cell lines. Invasion of these cells by green fluorescent protein-expressing gonococci is characterized by colocalization of gonococci with F actin. [53415 ] These cell lines may provide the basis for valid, reproducible in vitro models for studies on cervicovaginal physiology and infections and for testing pharmacological agents for intravaginal application. |
||
| Propagation: | ATCC complete growth medium: Keratinocyte-Serum Free medium (GIBCO-BRL 17005-042) with 0.1 ng/ml human recombinant EGF, 0.05 mg/ml bovine pituitary extract, and additional calcium chloride 44.1 mg/L (final concentration 0.4 mM) Atmosphere: air, 95%; carbon dioxide (CO2), 5% Temperature: 37.0°C |
||
| Subculturing: | Protocol: The cells should not be allowed to become confluent, subculture at 60 to 90% of confluence. Remove medium, and rinse with 0.25% trypsin, 0.53mM EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Neutralize the trypsin by adding a 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F12 medium containing 10% fetal bovine serum. Centrifuge the cell suspension at 1000 rpm for 10 minutes, resuspend the pellet in fresh serum-free growth medium, aspirate and dispense into new flasks. Cells will not attach well for 24 hours after subculture. Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:5 is recommended Medium Renewal: Every 2 to 3 days |
||
| Preservation: | Freeze medium: A 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F12 medium, 85%; fetal bovine serum, 10%; DMSO, 5% Storage temperature: liquid nitrogen vapor phase |
||
| Doubling Time: | 24 hrs | ||
| Related Products: | derived from same individual:ATCC CRL-2614 | ||
| References: | 52983: Fichorova RN, et al. Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol. Reprod. 57: 847-855, 1999. PubMed: 9314589 52984: Fichorova RN, Anderson DJ. Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol. Reprod. 60: 508-514, 1999. PubMed: 9916021 53415: Fichorova RN, et al. Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect. Immun. 69: 5840-5880, 2001. PubMed: 11500462 53416: Fichorova RN, et al. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J. Infect. Dis. 184: 418-428, 2001. PubMed: 11471099 |
||
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验相关实验
HPV 并不是宫颈癌唯一的「元凶」？这种微生物化身「帮凶」，共同促进癌症发生
。引人注目的是，在被 HPV E6E7 上调的基因中，28% 的基因在与沙眼衣原体共感染时恢复到与对照相似的表达水平，或者被强烈下调。 其中，E2F 家族成员是最显著的反向调节转录因子。E2F 靶基因被 HPV E6E7 显著上调，但在沙眼衣原体感染后下调。目前尚不清楚这种沙眼衣原体介导的对 HPV E6E7 诱导的 E2F 靶标的抑制将对宿主细胞和病原体产生什么影响。 为了研究两种病原体对 Rb-E2F1 途径的调节，研究人员用沙眼衣原体感染了 hCEcto 类器官和 hCEcto E6E7
a look from the following website just by clicking "Tyrosine Phosphorylation and Dimerization" http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WSN-43F85YV-2&_user=1111158&_coverDate=06%2F29%2F2001&_rdoc=1&_fmt=full&_orig=search
扫描仪中，都采用机械式的二维X，Y线性扫描技术实现，即X，Y方向都采用直线驱动器和直线导轨实现往复运动。此类装置，由于驱动系统的频率限制，驱动器的扫描惯性大，使得扫描效率低，分析时间相当长；并且往复行程长，对直线导轨的精度要求相当高。二、光机结合的二维扫描系统为同样实现生物芯片的二维扫描，我们的实验装置设计如图2，采用了振镜和大数值孔径的远心f-è物镜相结合实现X方向扫描，Y方向的运动仍采用直线驱动器和直线导轨实现。 系统中，对于f-è物镜，满足x＝2fè（è为振镜的摆动角度，f为物镜焦距）的线性
技术资料暂无技术资料 索取技术资料
End1/E6E7
询价
